1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with n,n-dimethylsphingenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felding-Habermann, B; Fenderson, BA; Hakomori, S; Handa, K; Igarashi, Y; Inokuchi, J; Park, LS; Radin, NS; Strassmann, G | 1 |
| Chatterjee, S; Kolmakova, A; Pili, R; Rajesh, M; Zang, D | 1 |
2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and n,n-dimethylsphingenine
| Article | Year |
|---|---|
A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis.
Topics: Animals; Cell Division; Ceramides; DNA Replication; Gangliosides; Glycosphingolipids; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred C3H; Morpholines; Phytohemagglutinins; Protein-Tyrosine Kinases; Receptors, Interleukin-2; Signal Transduction; Sphingosine; Stereoisomerism; T-Lymphocytes, Cytotoxic | 1990 |
VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo.
Topics: Animals; Antigens, CD; Blotting, Western; Cell Line; Cell Line, Tumor; Chromones; Endothelial Cells; Female; Fibroblast Growth Factor 2; Galactosyltransferases; Glucosyltransferases; Humans; Lactosylceramides; Mice; Mice, Nude; Morpholines; Neovascularization, Physiologic; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Lysosphingolipid; Sphingosine; Suramin; Vascular Endothelial Growth Factor A | 2009 |